Tocqueville Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13M | Sell |
82,008
-1,898
| -2% | -$257K | 0.17% | 134 |
|
|
2026
Q1 | $10.7M | Sell |
83,906
-809
| -1% | -$101K | 0.16% | 151 |
|
|
2025
Q4 | $10.3M | Sell |
84,715
-125
| -0.1% | -$14.3K | 0.15% | 156 |
|
|
2025
Q3 | $8.5M | Sell |
84,840
-146
| -0.2% | -$13.2K | 0.12% | 177 |
|
|
2025
Q2 | $7.05M | Sell |
84,986
-10,244
| -11% | -$817K | 0.11% | 186 |
|
|
2025
Q1 | $7.72M | Buy |
95,230
+27,020
| +40% | +$2.42M | 0.13% | 147 |
|
|
2024
Q4 | $6.14M | Sell |
68,210
-5,259
| -7% | -$510K | 0.1% | 161 |
|
|
2024
Q3 | $7.26M | Sell |
73,469
-21,848
| -23% | -$2.15M | 0.11% | 155 |
|
|
2024
Q2 | $8.84M | Sell |
95,317
-3,567
| -4% | -$320K | 0.15% | 136 |
|
|
2024
Q1 | $9.38M | Buy |
98,884
+5
| +0% | +$464 | 0.15% | 140 |
|
|
2023
Q4 | $8.83M | Sell |
98,879
-2,096
| -2% | -$156K | 0.16% | 140 |
|
|
2023
Q3 | $7.37M | Sell |
100,975
-39
| -0% | -$3.12K | 0.14% | 145 |
|
|
2023
Q2 | $8.4M | Sell |
101,014
-13,422
| -12% | -$1.12M | 0.15% | 137 |
|
|
2023
Q1 | $8.72M | Buy |
114,436
+1,670
| +1% | +$139K | 0.16% | 136 |
|
|
2022
Q4 | $9.36M | Sell |
112,766
-1,535
| -1% | -$124K | 0.18% | 140 |
|
|
2022
Q3 | $9.07M | Sell |
114,301
-5,159
| -4% | -$435K | 0.18% | 130 |
|
|
2022
Q2 | $8.87M | Buy |
119,460
+4,489
| +4% | +$337K | 0.16% | 144 |
|
|
2022
Q1 | $10.3M | Buy |
114,971
+23,475
| +26% | +$2.17M | 0.16% | 146 |
|
|
2021
Q4 | $10.2M | Buy |
91,496
+13,141
| +17% | +$1.58M | 0.14% | 157 |
|
|
2021
Q3 | $9.85M | Buy |
78,355
+13,151
| +20% | +$1.69M | 0.15% | 161 |
|
|
2021
Q2 | $8.83M | Buy |
65,204
+18,354
| +39% | +$2.41M | 0.13% | 178 |
|
|
2021
Q1 | $6.36M | Buy |
46,850
+700
| +2% | +$105K | 0.1% | 224 |
|
|
2020
Q4 | $6.5M | Sell |
46,150
-70
| -0.2% | -$8.97K | 0.11% | 205 |
|
|
2020
Q3 | $5.15M | Sell |
46,220
-75,000
| -62% | -$8.41M | 0.1% | 199 |
|
|
2020
Q2 | $13.6M | Sell |
121,220
-24,845
| -17% | -$2.45M | 0.28% | 84 |
|
|
2020
Q1 | $11.3M | Sell |
146,065
-7,615
| -5% | -$674K | 0.28% | 84 |
|
|
2019
Q4 | $14.6M | Buy |
153,680
+8,010
| +5% | +$693K | 0.22% | 126 |
|
|
2019
Q3 | $11.1M | Buy |
145,670
+9,550
| +7% | +$794K | 0.15% | 167 |
|
|
2019
Q2 | $11.9M | Sell |
136,120
-80
| -0.1% | -$6.82K | 0.15% | 169 |
|
|
2019
Q1 | $12.3M | Sell |
136,200
-13,390
| -9% | -$1.14M | 0.16% | 159 |
|
|
2018
Q4 | $10.7M | Buy |
149,590
+58,960
| +65% | +$4.75M | 0.16% | 159 |
|
|
2018
Q3 | $8.69M | Buy |
90,630
+2,535
| +3% | +$246K | 0.11% | 204 |
|
|
2018
Q2 | $8.39M | Sell |
88,095
-4,800
| -5% | -$441K | 0.11% | 205 |
|
|
2018
Q1 | $8.15M | Buy |
92,895
+70,255
| +310% | +$6.41M | 0.1% | 208 |
|
|
2017
Q4 | $1.92M | Buy |
22,640
+750
| +3% | +$62.8K | 0.02% | 436 |
|
|
2017
Q3 | $1.9M | Buy |
21,890
+300
| +1% | +$24.1K | 0.02% | 457 |
|
|
2017
Q2 | $1.67M | Buy |
21,590
+5,450
| +34% | +$387K | 0.02% | 444 |
|
|
2017
Q1 | $1.12M | Buy |
16,140
+354
| +2% | +$23.8K | 0.01% | 479 |
|
|
2016
Q4 | $934K | Sell |
15,786
-2,044
| -11% | -$126K | 0.01% | 500 |
|
|
2016
Q3 | $1.18M | Sell |
17,830
-110
| -0.6% | -$6.8K | 0.01% | 483 |
|
|
2016
Q2 | $970K | Hold |
17,940
| – | – | 0.01% | 507 |
|
|
2016
Q1 | $927K | Hold |
17,940
| – | – | 0.01% | 513 |
|
|
2015
Q4 | $1.26M | Sell |
17,940
-675
| -4% | -$46K | 0.02% | 501 |
|
|
2015
Q3 | $1.16M | Hold |
18,615
| – | – | 0.02% | 530 |
|
|
2015
Q2 | $1.56M | Sell |
18,615
-195
| -1% | -$15.2K | 0.02% | 492 |
|
|
2015
Q1 | $1.41M | Hold |
18,810
| – | – | 0.02% | 529 |
|
|
2014
Q4 | $1.17M | Buy |
+18,810
| New | +$1.07M | 0.01% | 553 |
|
|
2014
Q3 | – | Sell |
-52,005
| Closed | -$2.67M | – | 1300 |
|
|
2014
Q2 | $2.67M | Buy |
+52,005
| New | +$2.34M | 0.03% | 430 |
|
|
2013
Q4 | – | Sell |
-91,140
| Closed | -$3.92M | – | 1428 |
|
|
2013
Q3 | $3.92M | Sell |
91,140
-15,135
| -14% | -$613K | 0.05% | 333 |
|
|
2013
Q2 | $3.69M | Buy |
+106,275
| New | +$3.73M | 0.05% | 326 |
|
Other funds holding XBI
JFG
Tocqueville Asset Management's XBI Position: Q2 2026 in Review
Tocqueville Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 2.3% in Q2 2026, selling an estimated $257K and leaving 82,008 shares worth $13M. The position accounts for 0.17% of the portfolio, ranked #134.
Tocqueville Asset Management first reported a position in XBI in Q2 2013 and has held it in 50 quarters since. The position peaked at $14.6M in Q4 2019. 932 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- Tocqueville Asset Management held 82,008 shares of State Street SPDR S&P Biotech ETF worth $13M as of Q2 2026.
- Tocqueville Asset Management sold 1,898 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $257K.
- State Street SPDR S&P Biotech ETF made up 0.17% of Tocqueville Asset Management's portfolio in Q2 2026, its #134 holding.
- Tocqueville Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2013 and has held it in 50 quarters since.
- Tocqueville Asset Management's State Street SPDR S&P Biotech ETF position peaked at $14.6M in Q4 2019.
- 932 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on Tocqueville Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.